MRI of ARPKD liver disease
Contact
Description
The primary goal of this research study is to see if newtypes of magnetic resonance imaging (MRI) can be used to measure liver healthin children with autosomal recessive polycystic kidney disease (ARPKD) comparedto healthy controls. Both children with ARPKDand healthy children, aged 6 years and above can participate.
Eligibility and criteria
IRB Number:
20-018367
Eligible age range:
Clinical trial phase:
Pilot
Official title:
What to expect
Related specialties
We need families like you
Your time and participation make a difference in supporting the work of the Research Institute and children in our community. Learn more about opportunities to participate in our research.